A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis

Clinical trial NCT01609283 · COMPLETED

Trial details

NCT number: NCT01609283
Sponsor: Mayo Clinic
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Amyotrophic Lateral Sclerosis

Start date: 2012-05-01
Primary completion: 2019-01-31
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.